|
(b)(4).Only event year known: 2020.Complaint device = unknown.Sterile devices were received on 11/04/2020.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.What was the surgical procedure? how was the leak identified? how was the leak addressed? did the patient undergo any radiation or chemotherapy? what segment of colon was being removed? were any other stapling devices used to create anastomosis? were any issues noted with device during initial procedure? was the device difficult to close or fire? please provide a timeline of events.What was done in the reoperation? what is the current patient status? device analysis of sterile samples: the analysis results showed that the xr60g reloads (a) (b) (c) (d) (e) (f) (g) (h) were received sterile and with no apparent damage.The packages were opened and the reloads were tested for functionality with a test device.The device fired and formed all the staples as intended.The device fired without any difficulties, the staple line was complete, and the staples meet the staple form release criteria.As part of our quality process, the manufacturing records of this batch was reviewed, and the manufacturing standards were met prior to the release of this batch.Although there is no direct evidence of use error, the instructions for use do contain the following caution: make sure tissue to be stapled is properly positioned in the jaws before stapling.Bunching, stretching, or uneven loading of tissue could result in leakage, lack of hemostasis, or disruption of staple line.The event described could not be confirmed as the devices performed without any difficulties noted.A manufacturing record evaluation was performed for the finished device batch numbers, and no non-conformances were identified.If information is obtained that was not available for the initial report, a follow-up report will be field as appropriate.
|